
NAYA Biosciences Inc
NASDAQ:NAYA

Balance Sheet
Balance Sheet Decomposition
NAYA Biosciences Inc
Current Assets | 2m |
Cash & Short-Term Investments | 471.6k |
Receivables | 257.1k |
Other Current Assets | 1.2m |
Non-Current Assets | 15.1m |
Long-Term Investments | 2.9m |
PP&E | 2.8m |
Intangibles | 9.4m |
Balance Sheet
NAYA Biosciences Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
10
|
6
|
0
|
0
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
1
|
10
|
6
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Current Assets |
0
|
1
|
0
|
0
|
1
|
2
|
11
|
6
|
1
|
1
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
7
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
7
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
Total Assets |
0
N/A
|
1
+427%
|
0
-50%
|
0
-7%
|
1
+189%
|
2
+131%
|
11
+508%
|
10
-4%
|
4
-61%
|
21
+409%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
2
|
|
Accrued Liabilities |
3
|
3
|
4
|
4
|
3
|
0
|
1
|
1
|
1
|
1
|
|
Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
|
Total Current Liabilities |
4
|
4
|
5
|
5
|
4
|
2
|
2
|
1
|
3
|
8
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
4
|
3
|
2
|
2
|
11
|
|
Total Liabilities |
4
N/A
|
4
-3%
|
5
+13%
|
5
+7%
|
4
-33%
|
6
+57%
|
5
-6%
|
3
-39%
|
5
+61%
|
20
+294%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
Retained Earnings |
11
|
16
|
18
|
19
|
22
|
24
|
32
|
39
|
50
|
58
|
|
Additional Paid In Capital |
6
|
12
|
13
|
14
|
19
|
20
|
38
|
46
|
49
|
53
|
|
Total Equity |
4
N/A
|
4
+14%
|
5
-23%
|
5
-8%
|
3
+45%
|
4
-36%
|
6
N/A
|
7
+27%
|
1
N/A
|
1
N/A
|
|
Total Liabilities & Equity |
0
N/A
|
1
+427%
|
0
-50%
|
0
-7%
|
1
+189%
|
2
+131%
|
11
+508%
|
10
-4%
|
4
-61%
|
21
+409%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|